{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:47:55Z","timestamp":1792234075433,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1436700"],"award-info":[{"award-number":["21ZR1436700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273950, 82003772, 82103050, 82372669, 82072573, 82272913"],"award-info":[{"award-number":["82273950, 82003772, 82103050, 82372669, 82072573, 82272913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72922-7","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:57:36Z","timestamp":1778169456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLUT6-facilitated noncanonical glucose metabolic rewiring enables resistance to targeted cancer therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Huimin","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-9706","authenticated-orcid":false,"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinazhaer","family":"Aihemaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-7377","authenticated-orcid":false,"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-3030","authenticated-orcid":false,"given":"Baohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-5540","authenticated-orcid":false,"given":"Yuchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-5717","authenticated-orcid":false,"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5367-2949","authenticated-orcid":false,"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-392X","authenticated-orcid":false,"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"72922_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72922_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"72922_CR3","first-page":"333","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt, D. R. et al. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J. Clin. 71, 333\u2013358 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"72922_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"72922_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635\u2013649 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"72922_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan, A. C. & Tan, D. S. W. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. J. Clin. Oncol. 40, 611\u2013625 (2022).","journal-title":"J. Clin. Oncol."},{"key":"72922_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41571-024-00971-2","volume":"22","author":"F Zhou","year":"2025","unstructured":"Zhou, F. et al. The changing treatment landscape of EGFR-mutant non-small-cell lung cancer. Nat. Rev. Clin. Oncol. 22, 95\u2013116 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72922_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309 (2019).","journal-title":"Nature"},{"key":"72922_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","volume":"19","author":"AJ Cooper","year":"2022","unstructured":"Cooper, A. J., Sequist, L. V. & Lin, J. J. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. Nat. Rev. Clin. Oncol. 19, 499\u2013514 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72922_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck, J. et al. Advances in PET imaging of cancer. Nat. Rev. Cancer 23, 474\u2013490 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"72922_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41571-018-0081-4","volume":"15","author":"G Recondo","year":"2018","unstructured":"Recondo, G., Facchinetti, F., Olaussen, K. A., Besse, B. & Friboulet, L. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Nat. Rev. Clin. Oncol. 15, 694\u2013708 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72922_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg6428","volume":"13","author":"KR Zhang","year":"2021","unstructured":"Zhang, K. R. et al. Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Sci. Transl. Med 13, eabg6428 (2021).","journal-title":"Sci. Transl. Med"},{"key":"72922_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cmet.2019.09.014","volume":"30","author":"K Huang","year":"2019","unstructured":"Huang, K. et al. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer. Cell Metab. 30, 1107\u20131119 e1108 (2019).","journal-title":"Cell Metab."},{"key":"72922_CR14","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-21-4074","volume":"82","author":"MY Luo","year":"2022","unstructured":"Luo, M. Y. et al. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer Res 82, 3516\u20133531 (2022).","journal-title":"Cancer Res"},{"key":"72922_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chembiol.2023.05.005","volume":"30","author":"QM Lv","year":"2023","unstructured":"Lv, Q. M. et al. Cancer cell-autonomous cGAS-STING response confers drug resistance. Cell Chem. Biol. 30, 591\u2013605 e594 (2023).","journal-title":"Cell Chem. Biol."},{"key":"72922_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature14655","volume":"526","author":"D Deng","year":"2015","unstructured":"Deng, D. et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature 526, 391\u2013396 (2015).","journal-title":"Nature"},{"key":"72922_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tem.2020.12.006","volume":"32","author":"C Echeverria","year":"2021","unstructured":"Echeverria, C., Nualart, F., Ferrada, L., Smith, G. J. & Godoy, A. S. Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy. Trends Endocrinol. Metab. 32, 198\u2013211 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"72922_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI72873","volume":"125","author":"K Sellers","year":"2015","unstructured":"Sellers, K. et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J. Clin. Invest 125, 687\u2013698 (2015).","journal-title":"J. Clin. Invest"},{"key":"72922_CR19","doi-asserted-by":"crossref","unstructured":"Lin, Q.X. et al. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Adv Sci 7 (2020).","DOI":"10.1002\/advs.201903483"},{"key":"72922_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharm. Rev. 58, 621\u2013681 (2006).","journal-title":"Pharm. Rev."},{"key":"72922_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk, C. G. & Stehouwer, C. D. A. Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases. Physiol. Rev. 100, 407\u2013461 (2020).","journal-title":"Physiol. Rev."},{"key":"72922_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","volume":"562","author":"MJ Bollong","year":"2018","unstructured":"Bollong, M. J. et al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature 562, 600\u2013604 (2018).","journal-title":"Nature"},{"key":"72922_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tem.2022.11.004","volume":"34","author":"CG Schalkwijk","year":"2023","unstructured":"Schalkwijk, C. G., Micali, L. R. & Wouters, K. Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal. Trends Endocrinol. Metab. 34, 49\u201360 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"72922_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41401-020-0443-1","volume":"42","author":"CS Ma","year":"2021","unstructured":"Ma, C. S. et al. NRF2-GPX4\/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells. Acta Pharm. Sin. 42, 613\u2013623 (2021).","journal-title":"Acta Pharm. Sin."},{"key":"72922_CR25","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-0282","volume":"10","author":"MS Binkley","year":"2020","unstructured":"Binkley, M. S. et al. KEAP1\/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition. Cancer Discov. 10, 1826\u20131841 (2020).","journal-title":"Cancer Discov."},{"key":"72922_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","volume":"32","author":"W Ge","year":"2017","unstructured":"Ge, W. et al. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding. Cancer Cell 32, 561\u2013573.e566 (2017).","journal-title":"Cancer Cell"},{"key":"72922_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2019.11.012","volume":"31","author":"SE LeBoeuf","year":"2020","unstructured":"LeBoeuf, S. E. et al. Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids. Cell Metab. 31, 339\u2013350.e334 (2020).","journal-title":"Cell Metab."},{"key":"72922_CR28","doi-asserted-by":"crossref","unstructured":"Sayin, V. I. et al. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer. Elife 6, e28083 (2017).","DOI":"10.7554\/eLife.28083"},{"key":"72922_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"72922_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18020-8","volume":"11","author":"Q Wu","year":"2020","unstructured":"Wu, Q. et al. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nat. Commun. 11, 4205 (2020).","journal-title":"Nat. Commun."},{"key":"72922_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2017.07.014","volume":"67","author":"A Nagarajan","year":"2017","unstructured":"Nagarajan, A. et al. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Mol. Cell 67, 685\u2013701.e686 (2017).","journal-title":"Mol. Cell"},{"key":"72922_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30326-3","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Molecular basis for inhibiting human glucose transporters by exofacial inhibitors. Nat. Commun. 13, 2632 (2022).","journal-title":"Nat. Commun."},{"key":"72922_CR33","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-14-0254","volume":"74","author":"FL Byrne","year":"2014","unstructured":"Byrne, F. L. et al. Metabolic Vulnerabilities in Endometrial Cancer. Cancer Res 74, 5832\u20135845 (2014).","journal-title":"Cancer Res"},{"key":"72922_CR34","doi-asserted-by":"publisher","first-page":"E286","DOI":"10.1152\/ajpendo.00082.2018","volume":"315","author":"FL Byrne","year":"2018","unstructured":"Byrne, F. L., Olzomer, E. M., Brink, R. & Hoehn, K. L. Knockout of glucose transporter GLUT6 has minimal effects on whole body metabolic physiology in mice. Am. J. Physiol. Endocrinol. Metab. 315, E286\u2013E293 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"72922_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt, A. & Al-Hasani, H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflug. Arch. 472, 1273\u20131298 (2020).","journal-title":"Pflug. Arch."},{"key":"72922_CR36","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cmet.2018.02.003","volume":"27","author":"A Moraru","year":"2018","unstructured":"Moraru, A. et al. Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes. Cell Metab. 27, 926\u2013934.e928 (2018).","journal-title":"Cell Metab."},{"key":"72922_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.molcel.2014.04.026","volume":"54","author":"CM Ferrer","year":"2014","unstructured":"Ferrer, C. M. et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol. Cell 54, 820\u2013831 (2014).","journal-title":"Mol. Cell"},{"key":"72922_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.molcel.2019.07.007","volume":"76","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. alpha-Ketoglutarate-Activated NF-kappaB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development. Mol. Cell 76, 148\u2013162.e147 (2019).","journal-title":"Mol. Cell"},{"key":"72922_CR39","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ccell.2017.10.016","volume":"32","author":"E Cosset","year":"2017","unstructured":"Cosset, E. et al. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell 32, 856\u2013868.e855 (2017).","journal-title":"Cancer Cell"},{"key":"72922_CR40","doi-asserted-by":"crossref","unstructured":"Triner, D. et al. Myc-Associated Zinc Finger Protein Regulates the Proinflammatory Response in Colitis and Colon Cancer via STAT3 Signaling. Mol. Cell Biol. 38, e00386-18 (2018).","DOI":"10.1128\/MCB.00386-18"},{"key":"72922_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-021-01008-5","volume":"54","author":"H Ortabozkoyun","year":"2022","unstructured":"Ortabozkoyun, H. et al. CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated insulation at Hox clusters. Nat. Genet 54, 202\u2013212 (2022).","journal-title":"Nat. Genet"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72922-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72922-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72922-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:08:32Z","timestamp":1783984112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72922-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72922"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72922-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6166"}}